Montelukast, or montelukast sodium. Montelukast Sodium is relatively safe, but adverse reactions such as respiratory reactions, psychiatric reactions, gastrointestinal reactions, allergic reactions, etc. may occur after use, but the overall incidence is very low.
Montelukast sodium, a leukotriene receptor antagonist, is commonly available in granules, tablets, and chewable tablets. It is indicated for the prophylaxis and long-term treatment of asthma in children aged 2 to 14 years; it is also indicated for the relief of symptoms caused by allergic rhinitis.
Montelukast Sodium is for children, but adverse reactions such as respiratory reactions, psychiatric reactions, gastrointestinal reactions, allergic reactions, and other adverse reactions may occur after administration. The incidence of adverse reactions is low, and most of them will improve after stopping the drug.
1. Respiratory system reaction: some patients may have upper respiratory tract infection.
2. Psychiatric reactions: including aggressive behavior, excitement, anxiety, depression, loss of orientation perception, inattention and so on.
3. Gastrointestinal reactions: manifested as diarrhea, dyspepsia, nausea and vomiting.
4. Allergic reaction: patients who are allergic to the drug may develop rash, itching, urticaria, etc.. The drug should be stopped immediately.
Montelukast sodium, should be used under medical supervision, avoid unauthorized use of the drug to avoid adverse drug reactions. Children should be under the supervision of an adult to take Montelukast Sodium, after taking the drug, any symptoms of discomfort, should promptly consult a doctor to clarify the cause of the disease, to be targeted treatment.